Metabolic and Appetite Responses to a Whey Protein Preload Following Prior Exercise in Overweight Males

Obesity, Abdominal Clinical Trial

Official title:

Acute Metabolic and Second Meal Appetite Responses to a Whey Protein Preload Following Prior Moderate Intensity Exercise in Overweight and Obese Males

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02714309
• Other study ID #: HLSDA190116
• Status: Completed
• Phase: N/A
• First received: March 16, 2016
• Last updated: July 4, 2016
• Start date: March 2016
• Est. completion date: July 2016

Study information

• Verified date: July 2016
• Source: Northumbria University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: Research Ethics Committee
• Study type: Interventional

Clinical Trial Summary

Consuming whey protein may have beneficial effects on health, principally by having an impact on blood glucose metabolism, but also by affecting appetite. The purpose of this project is to investigate the effect of consuming whey protein preload prior to breakfast, following a bout of low/moderate intensity exercise (brisk walking), on glucose and lipids in the blood as well as on appetite.

It is hypothesised that the consumption of whey protein before a meal after prior low/moderate intensity exercise may positively affect postprandial handling as well as appetite sensations and consequently reduce intake at a subsequent meal.

Description:

A crossover design shall be implemented, whereby all participants complete 3 experimental trials in random order, separated by a minimum of 5 days.

Participants will be asked to record their dietary intake for 24 hours before each trial and will be provided with a standardised meal to consume at a set time the previous evening. At each visit participants shall report to the lab at approximately 08.00 hours following a 12 hour fast and having refrained from caffeine, alcohol and vigorous physical activity for 24 hours.

After determination of body mass and stature, a cannula shall be inserted into an antecubital vein in order to collect venous blood samples. A baseline blood sample (10ml) shall be collected, and visual analogue scales (VAS) completed in order to assess appetite sensations.

Following this a 30 minute exercise bout shall be completed in two of the trials, with 30 minutes of seated rest carried out in the control trial. Participants shall walk on a motorised treadmill at a predetermined speed designed to reflect 55% of estimated maximal aerobic capacity. Heart rate and perceived exertion will be sampled every three minutes, while expired air shall be sampled for two minute periods at 5, 15 and 25 minutes.

During the preload trial, participants shall consume a whey protein beverage 15 minutes after completion of the exercise bout. This will consist of 23g whey protein isolate powder (20g protein) combined with 200ml water and 10 drops of energy-free flavouring to create a milkshake-type beverage. In both other trials an isovolumetric bolus of similarly flavoured water shall be consumed. After a further 15 minutes participants shall consume the same mixed-macronutrient breakfast meal under all conditions, and will subsequently rest for a 240 minute period. An ad libitum pasta meal shall be consumed at the end of this period in all trials in order to assess subsequent energy intake. Regular blood samples shall be collected throughout.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: July 2016
• Est. primary completion date: July 2016
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years to 55 Years

Eligibility

Criteria for inclusion are as follows:

• Male

• Aged 18-55 years

• Abdominal obesity (Waist circumference > 102 cm)

• Sedentary (not currently participating in structured physical activity)

Criteria for exclusion are as follows:

• Cardiovascular, metabolic or renal disease

• Current illness

• Regular breakfast skipper

• Food allergies or intolerances

• Eating disorders

• Smoker

• Inadequate venous access

• Taking medication that may affect metabolism

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science

Related Conditions & MeSH terms

• Obesity, Abdominal
• Overweight

Intervention

Dietary Supplement:
• Whey protein
20 g whey protein isolate (Arla Foods Ingredients Group) added to 200ml water and served as a beverage

Other:
• Mixed macronutrient breakfast meal
A standardised mixed-macronutrient breakfast served to all participants. The macronutrient distribution of the breakfast is 13% protein, 70% carbohydrate, 17% fat (1958 kilojoules (kJ); 468 kcal total)
• Ad libitum lunch meal
A mixed-macronutrient lunch served to all participants ad libitum. The macronutrient distribution of the lunch is 14% protein, 51% carbohydrate, 35% fat
• Low/moderate intensity exercise
A 30 minute bout of treadmill walking is performed on a motorised treadmill at a low/moderate intensity (55% estimated VO2max)

Locations

Country	Name	City	State
United Kingdom	Faculty of Health and Life Sciences, Northumbria University	Newcastle upon Tyne	Tyne and Wear

Sponsors (1)

Lead Sponsor	Collaborator
Northumbria University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postprandial blood glucose responses	Blood glucose concentration determined in whole blood sampled at regular intervals post-breakfast	0-240 minutes post breakfast	No
Secondary	Energy intake at ad libitum lunch meal	Energy intake is assessed by recording the mass of food (of known composition) ingested during the lunch meal	240 minutes post breakfast breakfast	No